-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Guide
2026-09-15
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit IgG primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, and flow cytometry workflows. It is intended for research use only; assay-specific titration and controls are required, and the reagent should not be used for diagnostic, therapeutic, or unvalidated live-cell applications.
-
Saquinavir: Biomimetic Permeability Workflows
2026-09-15
Saquinavir can serve as a mechanistically defined HIV protease inhibitor control while biomimetic chromatography helps characterize drug–membrane interactions. This workflow combines IAM-LC, OT-CEC, and MS to support antiretroviral drug research, permeability screening, and carefully bounded translational studies.
-
n-Dodecyl-β-D-maltoside for WecA Assays
2026-09-14
DDM provides a gentle, tunable route for extracting and stabilizing difficult multi-pass membrane proteins such as WecA while preserving a workable environment for kinetic analysis. This guide connects detergent screening, affinity purification, UMP-based activity measurements, and troubleshooting into an applied workflow for membrane protein research and inhibitor discovery.
-
MK 0893: Glucagon Receptor Antagonist Workflows
2026-09-14
MK 0893 is a competitive, reversible glucagon receptor antagonist for connecting GCGR binding, cAMP signaling, and glucose-response phenotypes. This workflow-focused guide covers assay setup, in vivo translation, selectivity controls, and troubleshooting for type 2 diabetes research.
-
Antiarrhythmic Drugs and KCa2 Channels in AF
2026-09-13
The reference study systematically examined whether established antiarrhythmic drugs modulate human KCa2.2 and KCa2.3 channels, an atrial-enriched target proposed for safer atrial fibrillation therapy. Automated whole-cell patch-clamp data identified inhibition by dofetilide and propafenone, but the large potency gap relative to therapeutic free plasma exposure argues against KCa2 blockade as a major explanation for their clinical actions.
-
Partial BACE Inhibition and Synaptic Transmission
2026-09-12
Satir et al. showed that partial BACE inhibition can reduce amyloid beta secretion without measurably impairing synaptic transmission in cultured rat cortical neurons. The study supports a dose-dependent therapeutic window for Alzheimer’s disease research, while also showing that stronger inhibition was associated with reduced synaptic function.
-
HLTP1 Suppresses JNK in Liver Ischemia-Reperfusion Injury
2026-09-12
This study identifies human liver transplantation peptide 1 (HLTP1) through peptidomic analysis of clinical liver-transplant samples and shows that it reduces hepatic ischemia-reperfusion injury in mice and hepatocyte-like AML12 cells. The findings connect HLTP1 protection to suppression of JNK phosphorylation and apoptosis, while also establishing a translational framework for evaluating DNA fragmentation and cell-death endpoints.
-
Trichostatin A: From HDACs to Tumor Immunity
2026-09-11
Trichostatin A (TSA) is more than a broad HDAC inhibitor: it is a powerful probe for connecting chromatin acetylation with tumor-cell state and immunogenicity. This article translates CBX2–RACK1–HDAC1 biology into practical assay decisions while distinguishing established evidence from testable hypotheses.
-
FH1 Small Molecule for iHep Maturation
2026-09-11
FH1 supports a practical strategy for improving functional readouts in iPS-derived hepatocyte-like cells, with reported gains in albumin secretion, CYP3A4 levels, colony morphology, and AFP reduction. This guide connects FH1 handling with staged differentiation, multiparametric validation, troubleshooting, and carefully bounded applications in liver model and gene-regulation research.
-
Tofacitinib Repairs RA Macrophage Inflammation
2026-09-10
A 2026 study shows that Tofacitinib reverses the inflammatory, metabolic, and mitochondrial abnormalities induced by GM-CSF in rheumatoid arthritis macrophages. Its distinctive effect was linked to reduced GM-CSFRα expression and impaired STAT5 signaling, connecting cytokine control with restoration of macrophage regulatory and mitochondrial states.
-
CUDC-907: Practical Dual PI3K/HDAC Workflow
2026-09-10
CUDC-907 is a dual PI3K and HDAC inhibitor for controlled cell-based studies of PI3K/AKT signaling pathway inhibition, histone deacetylase activity, apoptosis, and cell-cycle progression. It is intended for scientific research workflows only and should not be used for diagnostic, therapeutic, or clinical applications.
-
CUDC-907: Practical PI3K/HDAC Workflow
2026-09-09
CUDC-907 (SKU A4097) is a dual PI3K and HDAC inhibitor for controlled studies of PI3K/AKT signaling, histone acetylation, cell-cycle behavior, and apoptosis in cultured cancer models. This guide covers preparation, starting treatment conditions, controls, and assay interpretation; the compound is for scientific research only and should not be used for diagnostic, therapeutic, or clinical applications.
-
PBA-Modified PAD4 Inhibitors Target Tumor NETs
2026-09-09
The reference study developed phenylboronic acid-modified PAD4 inhibitors to combine tumor-biased uptake with suppression of the PAD4–H3cit–NET pathway. Its lead compound reduced tumor growth and lung metastasis in mouse models while reshaping neutrophil and macrophage features, providing a mechanistic framework for studying tumor-directed PAD4 inhibition.
-
Rucaparib (AG-014699) in DNA Repair Workflows
2026-09-08
Rucaparib (AG-014699) supports controlled studies of PARP1 inhibition, DNA damage, and radiation response across prostate cancer and hepatocellular carcinoma models. This guide connects practical dosing, γ-H2AX and p53BP1 assays, spliceosome-linked biomarkers, transporter effects, and troubleshooting for reproducible cancer research.
-
Nurr1+ Neuron Gradients in the Rat Claustrum
2026-09-08
Fang, Wang, and Naumann combine developmental Nurr1 mapping with EdU birth dating to resolve when claustral and lateral cortical neuron populations arise in the rat. Their results reveal sequential neurogenesis and region-specific ventral-to-dorsal and posterior-to-anterior gradients, providing a framework for interpreting claustrum organization beyond static anatomical boundaries.